Vertex Pharmaceuticals stock is soaring. The FDA just approved its ...

Jan 31, 2025 · Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment. It’s the first new class ...

CouponFollow Extension

62%
OFF

Vertex Pharmaceuticals Stock Rises As FDA Approves Its Pain Pill

2 weeks from now

Jan 31, 2025 · Vertex Pharmaceuticals (VRTX +0.62%) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.

qz.com

31%
OFF

Vertex Pharmaceuticals Shares Gain After FDA Approves Non …

2 weeks from now

Shares of Vertex Pharmaceuticals VRTX5.31%increase; green up pointing triangle rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug …

wsj.com

6%
OFF

Vertex Stock Jumps After Non-Opioid Painkiller Gets FDA …

2 weeks from now

Jan 31, 2025 · Shares of Vertex Pharmaceuticals gained about 6% Friday morning, after the pharmaceutical company won U.S. approval for the first new non-opioid painkiller in decades. …

yahoo.com

6%
OFF

Vertex Stock Jumps After Non-Opioid Painkiller Gets FDA Approval

2 weeks from now

Jan 31, 2025 · Vertex will charge $15.50 a pill for Journavx, or $217 for a week’s prescription. (/Associated Press) Shares of Vertex Pharmaceuticals gained about 6% Friday morning, after …

wsj.com

2%
OFF

Vertex Pharmaceuticals Stock Jumps After FDA Approval For New …

2 weeks from now

The approval was largely expected, but shares of Vertex jumped 5.2% early Friday. The FDA approved the drug to treat acute pain, meaning short-term pain from a procedure or injury.

msn.com

8%
OFF

Vertex Pharmaceuticals (VRTX) Set For Painless Gains After FDA …

2 weeks from now

4 days ago · Vertex Pharmaceuticals shares surged 8% in post-market trading on January 30 after securing FDA approval for Journavx, also known as suzetrigine. The drug is the …

businessinsider.com

$7
OFF

FDA Approves Vertex’s Journavx As First New Pain Drug In Decades

2 weeks from now

Jan 30, 2025 · A week after Purdue Pharma and the Sackler family agreed to pay $7.4 billion to settle lawsuits stemming from the company’s opioid-based painkiller OxyContin, the FDA …

biospace.com

$10
OFF

Vertex Stock Flashes A Surprise Entry As Non-Opioid Pain Drug …

2 weeks from now

Nov 5, 2024 · 1/31/2025 Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped. 1/31/2025 Vertex …

investors.com

FAQs about Vertex Pharmaceuticals stock is soaring. The FDA just approved its ... Coupon?

Why did Vertex Pharmaceuticals stock rise 8% in off-hours trading?

Shares of Vertex Pharmaceuticals rose 8% in off-hours trading after the pharmaceutical company won U.S. approval for the first new non-opioid painkiller in decades. The Food and Drug Administration approved Vertex's suzetrigine to treat moderate to severe acute pain. The drug is set to be sold under the brand name Journavx. ...

How much does vertex suzetrigine cost?

The Food and Drug Administration approved Vertex's suzetrigine to treat moderate to severe acute pain. The drug is set to be sold under the brand name Journavx. Vertex will charge $15.50 per pill, or $217 for a week’s prescription. ...

How much will journavx sell in 2025?

He expects about $80 million in Journavx sales in 2025, somewhat lower than consensus, and has an Outperform rating on the stock with a $550 price target. Vertex shares are up only 3.2% over the past 12 months, through Thursday’s close. ...